<table id="t10" width="95%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 10. Lipid-altering Effects of Atorvastatin in Adolescent Boys and Girls with Heterozygous Familial Hypercholesterolemia or Severe Hypercholesterolemia (Mean Percent Change From Baseline at Endpoint in Intention-to-Treat Population)</caption>
<col align="left" valign="top" width="14%"></col>
<col align="center" valign="top" width="14%"></col>
<col align="center" valign="top" width="14%"></col>
<col align="center" valign="top" width="14%"></col>
<col align="center" valign="top" width="14%"></col>
<col align="center" valign="top" width="15%"></col>
<col align="center" valign="top" width="15%"></col>
<thead>
<tr>
<th>DOSAGE</th>
<th>N</th>
<th>Total-C</th>
<th>LDL-C</th>
<th>HDL-C</th>
<th>TG</th>
<th>Apolipoprotein B</th>
</tr>
</thead>
<tbody>
<tr>
<td>Placebo</td>
<td>47</td>
<td>-1.5</td>
<td>-0.4</td>
<td>-1.9</td>
<td>1.0</td>
<td>0.7</td>
</tr>
<tr>
<td>Atorvastatin</td>
<td>140</td>
<td>-31.4</td>
<td>-39.6</td>
<td>2.8</td>
<td>-12.0</td>
<td>-34.0</td>
</tr>
</tbody>
</table>